Immunotherapy Did Not Worsen LEMS in Patient With Lung Cancer

Immunotherapy Did Not Worsen LEMS in Patient With Lung Cancer

310878

Immunotherapy Did Not Worsen LEMS in Patient With Lung Cancer

A patient with extensive-stage small cell lung cancer and Lambert-Eaton myasthenic syndrome (LEMS) saw a marked decrease in his lung tumors following treatment with a combination of an immune checkpoint inhibitor and chemotherapy — all while having no LEMS flare-ups. That finding from a recent case report, according to the authors, supports the benefits of immune checkpoint inhibitors for treating cancer patients without the risk of worsening LEMS symptoms. The report, “An extensive-stage small-cell lung…

You must be logged in to read/download the full post.